Literature DB >> 20401546

Variation in hematopoietic potential of induced pluripotent stem cell lines.

Kasem Kulkeaw1, Yuka Horio, Chiyo Mizuochi, Minetaro Ogawa, Daisuke Sugiyama.   

Abstract

Induced pluripotent stem (iPS) cells were originally generated from somatic cells by ectopic expression of four transcription factor genes: Oct3/4, Sox2, Klf4 and c-Myc. Currently, iPS cell lines differ in tissue origin, the combination of factors used to construct them, the method of gene delivery and expression of pluripotency markers. Thus to evaluate iPS cells for haematotherapy, the hematopoietic potential among iPS lines should be compared. Here, we compare differentiation capacity of six iPS lines into mesodermal cells and hematopoietic cells (HCs) through embryoid body (EB) formation. We show that the mouse embryonic fibroblast (MEF)-derived iPS lines 20D17 and 178B5 resemble CCE ES cells in terms of morphology in culture, number and size of EBs and differentiation capacity into mesodermal cells compared to iPS cells derived from adults, although all iPS lines could form EBs. The number of mesodermal cells differentiated from MEF-derived iPS cell lines showed a 3.9-407-fold increase compared to that from iPS lines derived from adults. Furthermore, 178B5 iPS cells generated Ter119(+) erythroid cells (3.35%) efficiently in culture. We conclude that hematopoietic potential differs among the six lines and that MEF-derived 20D17 and 178B5 iPS cells generate HCs more efficiently than adult-derived iPS cells.

Entities:  

Mesh:

Year:  2010        PMID: 20401546     DOI: 10.1007/s12015-010-9150-5

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  24 in total

1.  Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation.

Authors:  Hans Jörg Fehling; Georges Lacaud; Atsushi Kubo; Marion Kennedy; Scott Robertson; Gordon Keller; Valerie Kouskoff
Journal:  Development       Date:  2003-09       Impact factor: 6.868

2.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

3.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

4.  Generation of mouse induced pluripotent stem cells without viral vectors.

Authors:  Keisuke Okita; Masato Nakagawa; Hong Hyenjong; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Science       Date:  2008-10-09       Impact factor: 47.728

5.  Hematopoietic commitment during embryonic stem cell differentiation in culture.

Authors:  G Keller; M Kennedy; T Papayannopoulou; M V Wiles
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

6.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  Hematopoietic development from human induced pluripotent stem cells.

Authors:  Claudia Lengerke; Matthias Grauer; Nina I Niebuhr; Tamara Riedt; Lothar Kanz; In-Hyun Park; George Q Daley
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

8.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

9.  Reprogramming of pancreatic beta cells into induced pluripotent stem cells.

Authors:  Matthias Stadtfeld; Kristen Brennand; Konrad Hochedlinger
Journal:  Curr Biol       Date:  2008-05-22       Impact factor: 10.834

10.  Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages.

Authors:  S I Nishikawa; S Nishikawa; M Hirashima; N Matsuyoshi; H Kodama
Journal:  Development       Date:  1998-05       Impact factor: 6.868

View more
  13 in total

1.  Modeling and therapy of human liver diseases using induced pluripotent stem cells: how far have we come?

Authors:  Alejandro Soto-Gutierrez; Edgar Tafaleng; Victoria Kelly; Jayanta Roy-Chowdhury; Ira J Fox
Journal:  Hepatology       Date:  2011-02       Impact factor: 17.425

2.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

Review 3.  Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.

Authors:  Zhengping Jiang; Yanmei Han; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2013-12-16       Impact factor: 11.530

4.  Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines.

Authors:  Jason A Mills; Kai Wang; Prasuna Paluru; Lei Ying; Lin Lu; Aline M Galvão; Dongbin Xu; Yu Yao; Spencer K Sullivan; Lisa M Sullivan; Helen Mac; Amel Omari; Jyh-Chang Jean; Steve Shen; Adam Gower; Avi Spira; Gustavo Mostoslavsky; Darrell N Kotton; Deborah L French; Mitchell J Weiss; Paul Gadue
Journal:  Blood       Date:  2013-08-12       Impact factor: 22.113

5.  Human-induced pluripotent stem cells as a source of hepatocyte-like cells: new kids on the block.

Authors:  C Busletta; E Novo; M Parola
Journal:  Hepatol Int       Date:  2011-07-23       Impact factor: 6.047

Review 6.  Mesodermal and hematopoietic differentiation from ES and iPS cells.

Authors:  Tomoko Inoue-Yokoo; Kenzaburo Tani; Daisuke Sugiyama
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

7.  Variation in mesodermal and hematopoietic potential of adult skin-derived induced pluripotent stem cell lines in mice.

Authors:  Tomoko Inoue; Kasem Kulkeaw; Satoko Okayama; Kenzaburo Tani; Daisuke Sugiyama
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

8.  The Stagnant Adaptation of Defined and Xeno-Free Culture of iPSCs in Academia.

Authors:  Joseph T Vecchi; Tetsuro Wakatsuki
Journal:  Arch Stem Cell Res       Date:  2016-11-08

9.  HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem Cells.

Authors:  Marina Jerebtsova; Namita Kumari; Min Xu; Gustavo Brito Alvim de Melo; Xiaomei Niu; Kuan-Teh Jeang; Sergei Nekhai
Journal:  Biology (Basel)       Date:  2012-07-26

Review 10.  Experimental limitations using reprogrammed cells for hematopoietic differentiation.

Authors:  Katharina Seiler; Motokazu Tsuneto; Fritz Melchers
Journal:  J Biomed Biotechnol       Date:  2011-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.